San Diego

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• High blood pressure4 trials
• Alzheimer disease1 trial
• Chronic kidney disease1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 24 trials
• Phase 11 trial
• Phase 31 trial

Status

• Completed4 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Alnylam Pharmaceuticals4 trials
• Arvinas Estrogen Receptor, Inc.1 trial
• TrueBinding, Inc.1 trial

Running trials

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting

Closed trials

• Completed

  Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)

  NCT06272487· Phase 2· Alnylam Pharmaceuticals· Source

• Terminated

  A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease

  NCT05476783· Phase 2· TrueBinding, Inc.· Source

• Completed

  ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer

  NCT05501769· Phase 1· Arvinas Estrogen Receptor, Inc.· Source

• Completed

  Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

  NCT05103332· Phase 2· Alnylam Pharmaceuticals· Source

• Completed

  A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension

  NCT04936035· Phase 2· Alnylam Pharmaceuticals· Source